Papageorgiou GI - Search Results

1

Perforated appendicitis induced by pembrolizumab: a case report and review of the literature.

Papageorgiou GI, Fergadis E, Skouteris N, Christakos E, Tsakatikas SA, Filippakou A, Papantoni E, Stanc G, Souka E, Valavanis C, Kosmas C. Papageorgiou GI, et al. Anticancer Drugs. 2022 Feb 1;33(2):208-213. doi: 10.1097/CAD.0000000000001247. Anticancer Drugs. 2022. PMID: 34538865

2

Notable response of a young adult with recurrent glioblastoma multiforme to vincristine-irinotecan-temozolomide and bevacizumab.

Papageorgiou GI, Tsakatikas SA, Fioretzaki RG, Kosmas C. Papageorgiou GI, et al. Anticancer Drugs. 2021 Mar 1;32(3):330-336. doi: 10.1097/CAD.0000000000001021. Anticancer Drugs. 2021. PMID: 33229903

3

Immunotherapy for cholangiocarcinoma: a 2021 update.

Charalampakis N, Papageorgiou G, Tsakatikas S, Fioretzaki R, Kole C, Kykalos S, Tolia M, Schizas D. Charalampakis N, et al. Immunotherapy. 2021 Sep;13(13):1113-1134. doi: 10.2217/imt-2021-0126. Epub 2021 Jun 30. Immunotherapy. 2021. PMID: 34190581 Review.

4

High grade neuroendocrine carcinoma of the breast, first line and maintenance immunotherapy.

Symeonidis D, Papageorgiou G, Liatsos A, Trihia H, Lianos E, Kosmas C. Symeonidis D, et al. Anticancer Drugs. 2022 Jan 1;33(1):91-93. doi: 10.1097/CAD.0000000000001126. Anticancer Drugs. 2022. PMID: 34232940

5

Central neurotoxicity induced by trastuzumab emtansine (T-DM1): a case report.

Papageorgiou GI, Symeonidis DG, Tsakatikas SA, Liatsos AD, Douglas KAA, Douglas VP, Moschos MM, Kosmas C. Papageorgiou GI, et al. Anticancer Drugs. 2021 Nov 1;32(10):1146-1149. doi: 10.1097/CAD.0000000000001117. Anticancer Drugs. 2021. PMID: 34232951

6

Case Report: Combination of Olaparib With Chemotherapy in a Patient With ATM-Deficient Colorectal Cancer.

Papageorgiou GI, Fergadis E, Skouteris N, Christakos E, Tsakatikas SA, Lianos E, Kosmas C. Papageorgiou GI, et al. Front Oncol. 2021 Dec 22;11:788809. doi: 10.3389/fonc.2021.788809. eCollection 2021. Front Oncol. 2021. PMID: 35004311 Free PMC article.

7

Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives.

Charalampakis N, Tsakatikas S, Schizas D, Kykalos S, Tolia M, Fioretzaki R, Papageorgiou G, Katsaros I, Abdelhakeem AAF, Sewastjanow-Silva M, Rogers JE, Ajani JA. Charalampakis N, et al. World J Gastrointest Oncol. 2022 Jan 15;14(1):181-202. doi: 10.4251/wjgo.v14.i1.181. World J Gastrointest Oncol. 2022. PMID: 35116110 Free PMC article. Review.

8

Identification of a Novel TSC2 c.170G>A Missense Variant: A Case Report and Elaboration on the Yield of Targeted Options against Tuberous Sclerosis Complex Manifestations.

Papageorgiou G, Skouteris N, Valavanis C, Stanc GM, Souka E, Charalampakis N. Papageorgiou G, et al. Rev Recent Clin Trials. 2023;18(4):304-312. doi: 10.2174/0115748871258042230921052344. Rev Recent Clin Trials. 2023. PMID: 37877150

9

Combining immunotherapy with PARP inhibitors. Is it possible to find the way through?

Papageorgiou GI, Skouteris N, Eleftheriou K, Kosmas C. Papageorgiou GI, et al. Immunotherapy. 2024;16(16-17):999-1003. doi: 10.1080/1750743X.2024.2398412. Epub 2024 Sep 13. Immunotherapy. 2024. PMID: 39268937 No abstract available.

10

Is the Patient Actually Failing on Enzalutamide? A Case Report and Issues to Consider in Enzalutamide-Resistant Oligoprogressive Metastatic Castrate-Resistant Prostate Cancer.

Papageorgiou GI, Skouteris N, Kosma A, Markouizou A, Charalampakis N. Papageorgiou GI, et al. Rev Recent Clin Trials. 2023;18(2):146-155. doi: 10.2174/1574887118666230412112136. Rev Recent Clin Trials. 2023. PMID: 37046193

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters